Changes in Hemostatic Variables Induced by Estrogen Replacement Therapy : Comparison of Transdermal and Oral Administration in a Crossover-Designed StudyFAIT, Tomas; VRABLIK, Michal; ZIZKA, Zdenek et al.Gynecologic and obstetric investigation. 2008, Vol 65, Num 1, pp 47-51, issn 0378-7346, 5 p.Article

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteinsVRABLIK, Michal; FAIT, Tomas; KOVAR, Jan et al.Metabolism, clinical and experimental. 2008, Vol 57, Num 8, pp 1088-1092, issn 0026-0495, 5 p.Article

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levelsHUBACEK, Jaroslav A; WANG, Wu-Wei; SKODOVA, Zdena et al.Clinical chemistry and laboratory medicine. 2008, Vol 46, Num 6, pp 773-777, issn 1434-6621, 5 p.Article

Folic acid does not improve surrogate markers of early atherosclerosis in atorvastatin-treated patientVRABLIK, Michal; STULC, Tomas; KASALOVA, Zdislava et al.Nutrition research (New York, NY). 2007, Vol 27, Num 3, pp 181-185, issn 0271-5317, 5 p.Article

MLXIPL variant in individuals with low and high triglyceridemia in white population in Central EuropeVRABLIK, Michal; CESKA, Richard; ADAMKOVA, Vera et al.Human genetics. 2008, Vol 124, Num 5, pp 553-555, issn 0340-6717, 3 p.Article